Watch on Demand! The Current State of Emerging Biotech Venture Capital & How to Successfully Raise Funds

by Bauke Anninga | November 2, 2023

51451_2023_EB_Symposium_1200x650_Speaker_Final

We invite you to the 4th Annual Biotech Start-up Symposium, a free, two-day event to help Biotech Start-ups navigate their path to commercialization. This Symposium features industry experts who present and discuss various aspects of emerging technologies and the latest trends in their fields.

On November 15^th, Day 2, you won’t want to miss the presentation by Bauke Anninga on The Current State of Emerging Biotech Venture Capital & How to Successfully Raise Funds

Here is an overview of what will be discussed:

M Ventures is the corporate venture capital arm of our company and provides investment and strategic advice to emerging biotech and life sciences companies. The financing landscape has seen a change in recent years and this presentations aims to provide an insight on the changes in the biotech VC landscape and tips from an investor’s perspective for companies that are fundraising.

Watch on Demand!

Bauke Anninga

Principal at M Ventures

Bauke is a Principal in the Biotechnology team at M Ventures. He serves on the boards of Immunitas Therapeutics, iOnctura, NanoSyrinx, and Pictor Labs. Before joining M Ventures, he was with Jefferies International in the Healthcare Investment Banking group in London (UK). During his time at Jefferies he advised on several financings and M&A transactions across the biotechnology, pharmaceutical and medical devices sectors. Bauke has a PhD in Cancer Studies from King’s College London (UK) and an MSc in Technical Medicine from the University of Twente (The Netherlands).